• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN EVERCROSS 035; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN EVERCROSS 035; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number AB35W05080135
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Stenosis (2263)
Event Date 12/15/2014
Event Type  Death  
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
On (b)(6) 2014, subject underwent intervention of a 40 mm, (b)(4) stenotic lesion in the left proximal sfa.The lesion was predilated with a 4 mm pta balloon at 10 atm resulting in a (b)(4) residual stenosis.The subject was then randomized to a bare balloon.The study balloon was inflated to 10 atm for 3 minutes with a 0% residual stenosis.No complications occurred during the procedure and the subject was discharged per plan on (b)(6) 2014.The subject completed all required study follow-up visits through 24 months, with the last visit occurring on (b)(6) 2016.On (b)(6) 2015, the subject received a diagnosis of suspected pancreatic cancer.Surgery was refused.Biliary stent was implanted ( date unknown).On (b)(6) 2015, it was noted that the target lesion had restenosis (left proximal sfa).On (b)(6) 2016 the subject underwent a revascularization procedure with pta to treat the restenosis of the target lesion.The subject was hospitalized with cholangiosepsis on (b)(6) 2016 and a secondary biliary stent was implanted as the first was occluded.On (b)(6) 2017 the subject was hospitalized for complaint of epigastric pain and significant tumor progression was noted.On (b)(6) 2017 the subject was hospitalized with suspected peritoneal carcinoma.On (b)(6) 2017 the clinical site became aware that the subject had died on (b)(6) 2017.Per the site, the cause of death is known pancreatic carcinoma (advanced); paralytic ileus and metabolic derailment.The physician does not believe that the device malfunction is the contributory cause for the death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERCROSS 035
Type of Device
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6847546
MDR Text Key85078403
Report Number2183870-2017-00381
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K082579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Health Professional
Type of Report Initial
Report Date 08/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/27/2016
Device Model NumberAB35W05080135
Device Catalogue NumberAB35W05080135
Device Lot Number9752511
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/08/2017
Date Device Manufactured05/28/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age79 YR
Patient Weight47
-
-